SNDX
NASDAQStockSyndax Pharmaceuticals, Inc.
$23.91-0.54 (-2.21%)
52-Week Range
$8.73
$24.16
Key Stats
Market Cap
2.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.46
Volume
1.3M
Avg Volume
1.5M
Performance
1M
+10.50%
3M
+14.89%
6M
+51.45%
YTD
+12.63%
1Y
+83.13%
3Y
+6.24%
5Y
+1.87%
Price Chart
ETF Exposure
SNDX is held by 65 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About SNDX ETF Exposure
Syndax Pharmaceuticals, Inc. (SNDX) is held by 65 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.1B, SNDX is a widely held institutional stock. The stock currently trades at $23.91. Investors can gain exposure to SNDX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SNDX, sorted by portfolio weight.